Pictet Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.1M | Sell |
1,546,391
-409,936
| -21% | -$13.5M | 0.05% | 312 |
|
|
2025
Q1 | $78.9M | Buy |
1,956,327
+44,328
| +2% | +$1.79M | 0.09% | 236 |
|
|
2024
Q4 | $89.9M | Sell |
1,911,999
-176,568
| -8% | -$8.31M | 0.1% | 215 |
|
|
2024
Q3 | $110M | Buy |
2,088,567
+320,405
| +18% | +$16.9M | 0.12% | 186 |
|
|
2024
Q2 | $95.8M | Buy |
1,768,162
+14,516
| +0.8% | +$786K | 0.11% | 195 |
|
|
2024
Q1 | $123M | Buy |
1,753,646
+381,402
| +28% | +$26.8M | 0.13% | 184 |
|
|
2023
Q4 | $115M | Sell |
1,372,244
-875,199
| -39% | -$73.1M | 0.13% | 186 |
|
|
2023
Q3 | $66.2M | Buy |
+2,247,443
| New | +$66.2M | 0.08% | 244 |
|